scispace - formally typeset
A

Alex Soriano

Researcher at University of Barcelona

Publications -  418
Citations -  14915

Alex Soriano is an academic researcher from University of Barcelona. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 50, co-authored 356 publications receiving 10544 citations. Previous affiliations of Alex Soriano include Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

TL;DR: Mortality associated with MRSA bacteremia was significantly higher when the empirical antibiotic was inappropriate and when vancomycin was empirically used for treatment of infection with strains with a high vancomYcin MIC (>1 microg/mL).
Journal ArticleDOI

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

Victoria Hall, +353 more
- 08 May 2021 - 
TL;DR: The SIREN study as discussed by the authors showed that the BNT162b2 vaccine can prevent both symptomatic and asymptomatic infection in working-age adults in the UK.
Journal ArticleDOI

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

V J Hall, +305 more
- 17 Apr 2021 - 
TL;DR: The SARS-CoV-2 Immunity and Reinfection Evaluation study as mentioned in this paper showed that a previous history of SARS infection was associated with an 84% lower risk of infection, with median protective effect observed 7 months following primary infection.
Journal ArticleDOI

Addition of a Macrolide to a β-Lactam-Based Empirical Antibiotic Regimen Is Associated with Lower In-Hospital Mortality for Patients with Bacteremic Pneumococcal Pneumonia

TL;DR: For patients with bacteremic pneumococcal pneumonia, not adding a macrolide to a beta-lactam-based initial antibiotic regimen is an independent predictor of in-hospital mortality, however, only a randomized study can definitively determine whether this association is due to a real effect of macrolides.